Ondansetron - Revision history

Danbot: Danbot moved page Ondansteron to Ondansetron over redirect: Fixing misspelling: Ondansteron → Ondansetron

2026-03-25T03:03:12Z

Danbot moved page Ondansteron to Ondansetron over redirect: Fixing misspelling: Ondansteron → Ondansetron

← Revisión anterior	Revisión del 03:03 25 mar 2026
(Sin diferencias)

Danbot: Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T21:57:30Z

Switch SMW query from broadtable to table format for better layout with TOC

← Revisión anterior		Revisión del 21:57 20 mar 2026
Línea 86:		Línea 86:
	\|?Has Route=Route		\|?Has Route=Route
	\|?Has Population=Population		\|?Has Population=Population
	\|format=~~broadtable~~		\|format=table
	\|headers=plain		\|headers=plain
	\|mainlabel=-		\|mainlabel=-

Danbot: Add SMW Indications by Condition query table

2026-03-20T18:20:02Z

Add SMW Indications by Condition query table

← Revisión anterior		Revisión del 18:20 20 mar 2026
Línea 75:		Línea 75:
	*Excretion: urine		*Excretion: urine
	*Mechanism of Action:selectively antagonizes serotonin 5-HT3 receptors		*Mechanism of Action:selectively antagonizes serotonin 5-HT3 receptors


			==Indications by Condition==
			''The following table is automatically generated from disease/condition pages across WikEM.''

			{{#ask:[[Has DrugName::Ondansetron]]
			\|?Has Indication=Indication
			\|?Has Dose=Dose
			\|?Has Context=Context
			\|?Has Route=Route
			\|?Has Population=Population
			\|format=broadtable
			\|headers=plain
			\|mainlabel=-
			\|sort=Has Indication
			\|limit=50
			}}

Ostermayer: Prepared the page for translation

2026-01-04T23:49:55Z

Prepared the page for translation

← Revisión anterior		Revisión del 23:49 4 ene 2026
Línea 1:		Línea 1:
			<languages/>
			<translate>

	==General==		==General==
	*Type: [[antiemetics]]
			*Type: [[Special:MyLanguage/antiemetics\|antiemetics]]
	*Dosage Forms: 4mg, 8mg		*Dosage Forms: 4mg, 8mg
	*Common Trade Names: Zofran		*Common Trade Names: Zofran


	==Adult Dosing==		==Adult Dosing==

	*Nausea/Vomiting: 4-8mg q4h, max 24mg a day		*Nausea/Vomiting: 4-8mg q4h, max 24mg a day

	==Pediatric Dosing==		==Pediatric Dosing==

	*Nausea/Vomiting: 0.1mg/kg IV q4h max dose at once:4-8mg, max 24mg		*Nausea/Vomiting: 0.1mg/kg IV q4h max dose at once:4-8mg, max 24mg
	*Gastroenteritis - Vomiting		*Gastroenteritis - Vomiting
Línea 15:		Línea 23:
	**Greater than 30 kg:		**Greater than 30 kg:
	***8mg orally disintegrating tablet dissolved orally as a single dose		***8mg orally disintegrating tablet dissolved orally as a single dose


	==Special Populations==		==Special Populations==
	*[[Drug Ratings in Pregnancy\|Pregnancy Rating]]: B
			*[[Special:MyLanguage/Drug Ratings in Pregnancy\|Pregnancy Rating]]: B
	**Consider avoiding in 1st trimester; conflicting data regarding possible risk of teratogenicity		**Consider avoiding in 1st trimester; conflicting data regarding possible risk of teratogenicity
	**Newer data argues that ondansetron is not the cause of birth defects<ref>Fejzo MS, et al. Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States. Reprod Toxicol. 2016 Jul;62:87-91.</ref>		**Newer data argues that ondansetron is not the cause of birth defects<ref>Fejzo MS, et al. Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States. Reprod Toxicol. 2016 Jul;62:87-91.</ref>
Línea 27:		Línea 37:
	**Adult: not defined		**Adult: not defined
	**Pediatric: not defined		**Pediatric: not defined


	==Contraindications==		==Contraindications==

	*Allergy to class/drug		*Allergy to class/drug
	*Congenital long QT syndrome		*Congenital long QT syndrome
	*Serotonin syndrome		*Serotonin syndrome


	==Adverse Reactions==		==Adverse Reactions==


	===Serious===		===Serious===

	*bronchospasm		*bronchospasm
	*steven-johnson syndrome		*steven-johnson syndrome
Línea 42:		Línea 58:
	*extrapyramidal symptoms		*extrapyramidal symptoms
	*blindness, transient		*blindness, transient

	===Common===		===Common===

	*headache		*headache
	*constipation		*constipation
Línea 50:		Línea 68:
	*urinary retention		*urinary retention
	*agitation		*agitation

	==Pharmacology==		==Pharmacology==

	*Half-life: 4.6-5.7 hour		*Half-life: 4.6-5.7 hour
	*Metabolism: liver		*Metabolism: liver
	*Excretion: urine		*Excretion: urine
	*Mechanism of Action:selectively antagonizes serotonin 5-HT3 receptors		*Mechanism of Action:selectively antagonizes serotonin 5-HT3 receptors


	==See Also==		==See Also==
Línea 60:		Línea 81:

	==References==		==References==

	<references/>		<references/>

	[[Category:Pharmacology]]		[[Category:Pharmacology]]
	[[Category:GI]]		[[Category:GI]]
			</translate>

Elcatracho: /* General */

2021-03-06T12:23:35Z

General

← Revisión anterior		Revisión del 12:23 6 mar 2021
Línea 1:		Línea 1:
	==General==		==General==
	*Type: [[antiemetics]]		*Type: [[antiemetics]]
	*Dosage Forms:4, 8		*Dosage Forms: 4mg, 8mg
	*Common Trade Names: Zofran		*Common Trade Names: Zofran

Sebenatar: /* Special Populations */

2021-01-13T20:02:50Z

Special Populations

← Revisión anterior		Revisión del 20:02 13 ene 2021
Línea 17:		Línea 17:

	==Special Populations==		==Special Populations==
	*[[Drug Ratings in Pregnancy\|Pregnancy Rating]]: C		*[[Drug Ratings in Pregnancy\|Pregnancy Rating]]: B
	**Consider avoiding in 1st trimester; conflicting data regarding possible risk of teratogenicity		**Consider avoiding in 1st trimester; conflicting data regarding possible risk of teratogenicity
	**Newer data argues that ondansetron is not the cause of birth defects<ref>Fejzo MS, et al. Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States. Reprod Toxicol. 2016 Jul;62:87-91.</ref>		**Newer data argues that ondansetron is not the cause of birth defects<ref>Fejzo MS, et al. Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States. Reprod Toxicol. 2016 Jul;62:87-91.</ref>

ClaireLewis at 00:44, 23 September 2019

2019-09-23T00:44:59Z

← Revisión anterior		Revisión del 00:44 23 sep 2019
Línea 1:		Línea 1:
	==General==		==General==
	*Type: ~~anti-emetic~~		*Type: [[antiemetics]]
	*Dosage Forms:4, 8		*Dosage Forms:4, 8
	*Common Trade Names: Zofran		*Common Trade Names: Zofran
Línea 40:		Línea 40:
	*torsades de pointes		*torsades de pointes
	*serotonin syndrome		*serotonin syndrome
	*extrapyramidal SX		*extrapyramidal symptoms
	*blindness, transient		*blindness, transient
	===Common===		===Common===
Línea 63:		Línea 63:

	[[Category:Pharmacology]]		[[Category:Pharmacology]]
			[[Category:GI]]

Sesondheim: /* Special Populations */

2018-07-22T16:27:01Z

Special Populations

← Revisión anterior		Revisión del 16:27 22 jul 2018
Línea 21:		Línea 21:
	**Newer data argues that ondansetron is not the cause of birth defects<ref>Fejzo MS, et al. Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States. Reprod Toxicol. 2016 Jul;62:87-91.</ref>		**Newer data argues that ondansetron is not the cause of birth defects<ref>Fejzo MS, et al. Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States. Reprod Toxicol. 2016 Jul;62:87-91.</ref>
	*Lactation:safety unknown		*Lactation:safety unknown
	**Adult:		*Renal Dosing:
	*~~Renal Dosing~~:not defined		**Adult: not defined
			**Pediatric: not defined
	*Hepatic Dosing: not defined		*Hepatic Dosing: not defined
	**~~Pediatric:~~		**Adult: not defined
	*Hepatic Dosing: not defined		**Pediatric: not defined
	*~~Renal Dosing~~:not defined

	==Contraindications==		==Contraindications==
	*Allergy to class/drug		*Allergy to class/drug
	*~~congenital~~ long QT syndrome		*Congenital long QT syndrome
			*Serotonin syndrome

	==Adverse Reactions==		==Adverse Reactions==
	===Serious===		===Serious===

Mholtz at 06:50, 13 July 2017

2017-07-13T06:50:01Z

← Revisión anterior		Revisión del 06:50 13 jul 2017
Línea 55:		Línea 55:

	==See Also==		==See Also==


	==References==		==References==
			<references/>

	~~<references/>~~
	[[Category:Pharmacology]]		[[Category:Pharmacology]]

Rossdonaldson1: /* Special Populations */

2017-05-17T03:44:11Z

Special Populations

← Revisión anterior		Revisión del 03:44 17 may 2017
Línea 17:		Línea 17:

	==Special Populations==		==Special Populations==
	*[[Drug Ratings in Pregnancy\|Pregnancy Rating]]: C ~~(consider~~ avoiding in 1st trimester; conflicting data regarding possible risk of teratogenicity)		*[[Drug Ratings in Pregnancy\|Pregnancy Rating]]: C
			**Consider avoiding in 1st trimester; conflicting data regarding possible risk of teratogenicity
			**Newer data argues that ondansetron is not the cause of birth defects<ref>Fejzo MS, et al. Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States. Reprod Toxicol. 2016 Jul;62:87-91.</ref>
	*Lactation:safety unknown		*Lactation:safety unknown
	**Adult:		**Adult: